lung cancer

News

ASCO: TIGIT returns with Roche, Gilead data

A year ago, enthusiasm for a new generation of cancer immunotherapies targeting TIGIT started to wane, after Roche’s tiragolumab was hit by two

News

AstraZeneca backs AI-based lung cancer diagnosis pilot in UK

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists d

News

UK imaging centre backs study of Brainomix' AI for cancer ca...

UK medtech company Brainomix has secured backing from a UK government-funded agency for a year-long study of its artificial intelligence-powered platform to monitor patients with lung cance

News

Takeda farms out cancer drug alisertib to Puma Biotech

Takeda has decided that there is a future for its aurora kinase A inhibitor alisertib after it failed a phase 3 trial in lymphoma – but the company won't be taking the drug forward itself.<

News

Groundbreaking cancer breathalyser developer secures £5m fun...

Funding will aid in ongoing cancer detection trials.

News

Owlstone’s breath diagnostic could ‘disrupt health insurance...

The venture capital arm of the UK’s biggest insurance firm Aviva is to invest $5 million (£4m) in Owlstone Medical, one of the country’s most promising and potentially groundbreaking diagno

ASCO: TIGIT returns with Roche, Gilead data

AstraZeneca backs AI-based lung cancer diagnosis pilot in UK

UK imaging centre backs study of Brainomix' AI for cancer ca...

Takeda farms out cancer drug alisertib to Puma Biotech

Groundbreaking cancer breathalyser developer secures £5m fun...

Owlstone’s breath diagnostic could ‘disrupt health insurance...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

lung cancer

Editor's Picks